Table 2 MDS patients multivariate analysis.

From: Differential U2AF1 mutation sites, burden and co-mutation genes can predict prognosis in patients with myelodysplastic syndrome

Factors

HR

95%CI

p value

Chromosome 7 abnormality

3.885

2.117~7.131

< 0.001

EZH2 mutation

8.523

2.558~28.395

< 0.001

TP53 mutation

4.532

1.885~10.895

0.001

CBL mutation

4.286

1.294~14.193

0.017

U2AF1 VAF > 40%

3.261

1.654~6.430

0.001

Back to article page